EHC Maintained by Barclays -- Price Target Raised to $144

Barclays has kept its rating on Encompass Health Corporation (EHC) unchanged while increasing its price target to $144, signaling continued analyst confidence in the inpatient rehabilitation company. Encompass Health operates a large network of rehabilitation hospitals that provide physical, occupational, and speech therapy services to patients recovering from strokes, orthopedic surgeries, and other conditions.

Read full article at GuruFocus ↗

About this summary. The text above is a short summary written for this site. The original article is hosted by GuruFocus at the link above; this site does not reproduce the full article. Verify against the source before relying on specific details.